2022.11.10
Increase R&D investment, BGI supports accurate nucleic acid detection in multiple dimensions
Since the outbreak of COVID-19, China has effectively controlled the virus with strong technology, and formulated relevant management policies in time, so that people's lives can quickly return to normal.
Since the outbreak of COVID-19, China has effectively controlled the virus with strong technology, and formulated relevant management policies in time, so that people's lives can quickly return to normal.
As the founder of China's gene industry, BGI has developed a series of COVID-19 detection products and built a fire eye nucleic acid detection laboratory based on advanced gene detection technology and a scientific research platform with advanced technology and complete configuration.
Related News
2022.11.10
Science: Major breakthrough! The copyright of the one-time multiple nucleic acid detection platform developed by Zhang Feng's team based on CRISPR belongs to the author.
In a new study, a rapid and cheap highly sensitive CRISPR based diagnostic tool - SHERLOCK (Specific High Sensitivity Enzymatic Reporter UnLOCK) was developed for the first time. The researchers greatly enhanced the function of this tool and developed a micro strip test method, which allows the naked eye to observe the test results without using expensive equipment. Relevant research results were published online in Science on February 15, 2018, with the title of "Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6".
Details
2022.11.10
Where are the investment opportunities behind nucleic acid testing?
If the genetic material of the virus, nucleic acid, can be found in the human body, it is undoubtedly the conclusive evidence that the person is infected. Since the outbreak of COVID-19 pneumonia, nucleic acid detection kits have replaced traditional medical images and become the final barrier between confirmed patients and suspected patients.
Details
